Web Results

Initial Regimen | Johns Hopkins HIV Guide

www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545104/all/Initial_Regimen

Mar 27, 2016 ... Gulick RM et al: Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

A Novel Method for Determining the Inhibitory Potential of Anti-HIV ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3385974/

Equation 4 linearizes the dose-response curves by plotting log (fa/fu) vs. log (D). m is the slope of this line. ... on experimental approaches to measure cut-off IQ values is lacking (reviewed by Morse, G.D. et al and la Porte, C. [33, 34]). ..... Gulick RM, et al. ... Johns Hopkins Medicine Health Publishing Business Group; 2007.

The seductive allure is a reductive allure - School of Arts & Sciences

www.sas.upenn.edu/~deenas/papers/hopkins-et-al-cognition2016.pdf

Taylor, & Hopkins, 2015), it is still unclear why this effect happens. One possibility is ... brain in plain language (e.g., ''brain scans”: Weisberg et al., 2015, ... Van Gulick, 2016). ...... adjacent pairs of fields (e.g., physics vs. chemistry, chemistry vs.

HOPKINS et al. v. UNITED STATES. | US Law | LII / Legal ...

www.law.cornell.edu/supremecourt/text/171/578

171 U.S. 578 (19 S.Ct. 40, 43 L.Ed. 290). HOPKINS et al. v. UNITED STATES. No. 210. Decided: October 24, 1898. opinion, PECKHAM [HTML]. This suit was ...

Antiretroviral therapy in the treatment of HIV-associated nephropathy

ndt.oxfordjournals.org/content/21/10/2809.full

Jul 24, 2006 ... The Johns Hopkins Institutional Review Board approved the research protocol. HIVAN ..... Murphy RL, Gulick RM, DeGruttola V, et al. (1999) ...

Ten Years of HAART: Foundation for the Future - Medscape Education

www.medscape.org/viewarticle/523119

... MD, Johns Hopkins University School of Medicine, Baltimore, Maryland, presented a plenary lecture, "Ten Years of HAART: Principles for the Future. .... Head-to-head comparison of NNRTI- vs PI-based HAART: Results of ACTG .... Robbins GK, De Gruttola V, Shafer RW, et al. ... Gulick RM, Ribaudo HJ, Shikuma CM, et al.

PDF(78K) - Wiley Online Library

onlinelibrary.wiley.com/doi/10.1111/tmi.12237/pdf

1 Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2 The Aurum Institute ... time of detection of viraemia (Marconi et al. 2008;. Hoffmann et ... (Gulick et al. 1997 .... Johnston V, Fielding K, Charalambous S et al. (2012) Second ...

Estate of Kalt - 16 Cal.2d 807 - Thu, 12/26/1940 | California ... - scocal

scocal.stanford.edu/opinion/estate-kalt-25279

EARL D. KALT et al., Appellants, v. LEO V. YOUNGWORTH, as Administrator, etc. , Respondent. COUNSEL. Wolfson .... Allen, 7 Cal.2d 468 [60 PaCal.2d 1026]; Hopkins v. White, 20 Cal. .... Gulick, 39 N. J. Eq. 401; Myrover v. French, 73 [16 ...

Johns Hopkins University v. Alcon Laboratories Inc. et al - RPX Search

search.rpxcorp.com/lit/dedce-57311-johns-hopkins-university-v-alcon-laboratories

Johns Hopkins University v. Alcon Laboratories Inc. et al. 1:15-cv-00525; Filed: 06/23/2015; Case Updated Daily; Latest Docket Entry: 09/16/2016; PACER.

Patients Videotaped By Johns Hopkins Doc Enter Deal Talks - Law360

www.law360.com/articles/485796/patients-videotaped-by-johns-hopkins-doc-enter-deal-talks

Nov 4, 2013 ... 19, two weeks after an underling tipped off Johns Hopkins higher-ups ... The case is Jane Doe No. 1 et al. v. The Johns Hopkins Hospital et al., ...

More Info

Zidovudine (AZT) | Johns Hopkins Antibiotic (ABX) Guide

www.hopkinsguides.com

May 28, 2014 ... Zidovudine (AZT) answers are found in the Johns Hopkins Antibiotic (ABX) ... Gulick RM et al: Three- vs four-drug antiretroviral regimens for the ...

Durable HIV RNA resuppression after virologic failure while ... - NCBI

www.ncbi.nlm.nih.gov

2009; Hoffmann et al. 2009). ... 2005; Gulick et al. 1997 ... Ethics approvals were provided by Johns Hopkins University and the University of KwaZulu-Natal.

Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment ...

jama.jamanetwork.com

Aug 16, 2006 ... ObjectiveTo compare the safety/efficacy of 3-drug vs 4-drug regimens for initial treatment of HIV-1 infection. ... *Details reported in Gulick et al.